The outlook revision is due to a number of factors, including CHS’ strong market position, solid operating profitability and its planned construction of a new hospital tower.
Fitch also affirmed the “A” rating on CHS’ series 2013 revenue bonds.
More articles on healthcare finance:
Puerto Rico debt measure bill heads to President Obama
S&P raises Chesire Medical Center’s rating to ‘A’
Fitch affirms King’s Daughters Medical Center’s ‘A-‘ rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
